| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |